期刊文献+

自噬在非酒精性脂肪性肝病中的变化及作用 被引量:2

The change and function of autophagy in nonalcoholic fatty liver disease
原文传递
导出
摘要 自噬是一种溶酶体依赖性降解途径,已有大量研究报道,自噬参与了非酒精性脂肪性肝病(NAFLD)的发生及发展。在NAFLD早期,自噬增强,并可以通过抑制引起NAFLD的“二次打击”延缓NAFLD的进展。在NAFLD晚期,由于自噬相关基因(Atg)7降解、哺乳动物雷帕霉素靶蛋白通路过度激活、高胰岛素血症、自噬一溶酶体蛋白水解功能减弱、自噬体膜及溶酶体膜脂质构成改变、肝细胞内钙离子水平增加引起自噬减弱,加重了NAFLD。 Autophagy is a pathway of degradation dependent on lysosome. A number of studies reported autophagy was involved in the occurrence and development of nonalcoholic fatty liver disease (NAFLD). Autophagy is enhanced in the early stage of NAFLD, and can delay the progress of NAFLD by inhibiting the "secondary stroke" which can induce NAFLD. In the late stage of NAFLD, degradation of autophagy related gene (Atg)7, activation of excessive mammalian rapamycin target protein pathway, hyperinsulinemia, dysfunction of autophagy-lysosome membrane protein hydrolysis, change of lipid composition in autophagnsome and lysosome membrane, increase of calcium in the hepatocyte can inhibit autophagy, thus aggravate NAFLD.
出处 《国际内分泌代谢杂志》 2017年第1期11-13,共3页 International Journal of Endocrinology and Metabolism
基金 山西省归国留学基金资助项目(2011-108) 山西省自然科学基金资助项目(2013011048-3) 山西省卫计委科技攻关计划项目(2014002)
关键词 自噬 非酒精性脂肪性肝病 哺乳动物雷帕霉素靶蛋白 Autophagy Nonalcoholic fatty liver disease Mammalian rapamycin target protein
  • 相关文献

参考文献3

二级参考文献80

  • 1朱伦,陈增良.mTOR的结构与功能[J].国际病理科学与临床杂志,2006,26(1):31-34. 被引量:13
  • 2Schmidt A, Bickle M, Beck T, et al. The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2[J]. Cell, 1997, 88(4) :531-542.
  • 3Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the fictor-mTOR complex [ J ]. Science,2005, 307(5712) :1098-1101.
  • 4Ali SM, Sabatini DM. Structure of S6 kinase 1 determines whether raptor-mTOR or rietor-mTOR phospharylates its hydrophobic motif site[J]. J Biol Chem, 2005, 280(20) :19445-19448.
  • 5Burnett PE, Barrow RK, Cohen NA, et al. BAFTI phosphorylation of the translational regulators pT0 S6 kinase and 4E-BP1 [ J ]. Proc Natl Acad Sci USA, 1998, 95(4) :1432-1437.
  • 6Pende M, Kozma SC, Jaquet M, et al. Hypoinsulinaemia, glucose intolerance and diminished beta-cell siza in S6K1-deficient mice[J]. Nature, 2000, 408(6815):994-997.
  • 7Gera JF, Mellinghoff IK, Shi Y, et al. AKT activity determines sensitivity to mammalian target of rapamycin(roTOR) inhibitors by regulating cyclin D1 and c-myc expression[J]. J Biol Chem, 2004, 279(4) :2737-2736.
  • 8Wullschleger S, Loewith R, Oppliger W, et al. Molecular organization of target of rapamycin complex 2 [ J ]. J Biol Chem, 2005, 280( 35 ) : 30697-30704.
  • 9Nissim H, Nahum S. Upstream and downstream of mTOR[ J]. Genes Dev, 2004, 18(16) :1926-1945.
  • 10Andrade M, Bork P. HEAT repeats in the Huntington's disease protein[J]. Nat Genet, 1995, 11(2):115-116.

共引文献58

同被引文献19

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部